Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Arrhythmias

  Free Subscription


Articles published in Heart

Retrieve available abstracts of 152 articles:
HTML format
Text format



Single Articles


    October 2019
  1. CHOU YL, Liou JT, Cheng CC, Tsai MC, et al
    The association of ischaemic stroke in patients with heart failure without atrial flutter/fibrillation.
    Heart. 2019 Oct 3. pii: heartjnl-2019-315646. doi: 10.1136/heartjnl-2019-315646.
    PubMed     Text format     Abstract available


    September 2019
  2. WU VC, Wu M, Aboyans V, Chang SH, et al
    Female sex as a risk factor for ischaemic stroke varies with age in patients with atrial fibrillation.
    Heart. 2019 Sep 26. pii: heartjnl-2019-315065. doi: 10.1136/heartjnl-2019-315065
    PubMed     Text format     Abstract available


  3. STOEVELAAR R, Brinkman-Stoppelenburg A, van Driel AG, van Bruchem-Visser RL, et al
    Implantable cardioverter defibrillator deactivation and advance care planning: a focus group study.
    Heart. 2019 Sep 19. pii: heartjnl-2019-315721. doi: 10.1136/heartjnl-2019-315721
    PubMed     Text format     Abstract available


  4. JAME S, Barnes G
    Stroke and thromboembolism prevention in atrial fibrillation.
    Heart. 2019 Sep 18. pii: heartjnl-2019-314898. doi: 10.1136/heartjnl-2019-314898
    PubMed     Text format     Abstract available


  5. AHN MS, Yoo BS, Yoon J, Lee SH, et al
    Guideline-directed therapy at discharge in patients with heart failure and atrial fibrillation.
    Heart. 2019 Sep 6. pii: heartjnl-2019-315240. doi: 10.1136/heartjnl-2019-315240.
    PubMed     Text format     Abstract available


  6. OTTO CM
    Heartbeat: Predictors of left atrial thrombus in patient with atrial fibrillation.
    Heart. 2019;105:1293-1294.
    PubMed     Text format    


    August 2019
  7. WIJESURENDRA RS, Casadei B
    Mechanisms of atrial fibrillation.
    Heart. 2019 Aug 23. pii: heartjnl-2018-314267. doi: 10.1136/heartjnl-2018-314267
    PubMed     Text format     Abstract available


  8. ZHANG H, El-Am EA, Thaden JJ, Pislaru SV, et al
    Atrial fibrillation is not an independent predictor of outcome in patients with aortic stenosis.
    Heart. 2019 Aug 22. pii: heartjnl-2019-314996. doi: 10.1136/heartjnl-2019-314996
    PubMed     Text format     Abstract available


  9. FROEHLICH L, Meyre P, Aeschbacher S, Blum S, et al
    Left atrial dimension and cardiovascular outcomes in patients with and without atrial fibrillation: a systematic review and meta-analysis.
    Heart. 2019 Aug 17. pii: heartjnl-2019-315174. doi: 10.1136/heartjnl-2019-315174
    PubMed     Text format     Abstract available


  10. PERSSON AP, Fedorowski A, Hedblad B, Persson M, et al
    Heart rate and premature atrial contractions at 24hECG independently predict atrial fibrillation in a population-based study.
    Heart. 2019 Aug 12. pii: heartjnl-2019-315119. doi: 10.1136/heartjnl-2019-315119
    PubMed     Text format     Abstract available


    July 2019
  11. HENDRIKS J, Stromberg A
    Gender differences in atrial fibrillation: patient-reported outcomes beyond symptom management alone.
    Heart. 2019 Jul 11. pii: heartjnl-2019-315288. doi: 10.1136/heartjnl-2019-315288
    PubMed     Text format    


    June 2019
  12. GLASS G, O'Connor R, Brady WJ
    Useful addition to acute myocardial infarction diagnosis in patients with left bundle branch block: an algorithm using electrocardiographic and biomarker analysis.
    Heart. 2019 Jun 27. pii: heartjnl-2019-315380. doi: 10.1136/heartjnl-2019-315380
    PubMed     Text format    


  13. JONES NR, Taylor KS, Taylor CJ, Aveyard P, et al
    Weight change and the risk of incident atrial fibrillation: a systematic review and meta-analysis.
    Heart. 2019 Jun 22. pii: heartjnl-2019-314931. doi: 10.1136/heartjnl-2019-314931
    PubMed     Text format     Abstract available


  14. MALIK AH, Yandrapalli S, Aronow WS, Panza JA, et al
    Oral anticoagulants in atrial fibrillation with valvular heart disease and bioprosthetic heart valves.
    Heart. 2019 Jun 14. pii: heartjnl-2019-314767. doi: 10.1136/heartjnl-2019-314767
    PubMed     Text format     Abstract available


  15. TAN ESJ, Tay WT, Teng TK, Richards AM, et al
    The diabetes-atrial fibrillation paradox.
    Heart. 2019;105:893.
    PubMed     Text format    


  16. OTTO CM
    Heartbeat: Diagnosis of subclinical atrial fibrillation by physicians and patients.
    Heart. 2019;105:809-811.
    PubMed     Text format    


    May 2019
  17. FLORIA M, Tanase DM
    Atrial fibrillation type and renal dysfunction: new challenges in thromboembolic risk assessment.
    Heart. 2019 May 31. pii: heartjnl-2019-315212. doi: 10.1136/heartjnl-2019-315212
    PubMed     Text format    


  18. NESTELBERGER T, Cullen L, Lindahl B, Reichlin T, et al
    Diagnosis of acute myocardial infarction in the presence of left bundle branch block.
    Heart. 2019 May 29. pii: heartjnl-2018-314673. doi: 10.1136/heartjnl-2018-314673
    PubMed     Text format     Abstract available


  19. GLEASON KT, Dennison Himmelfarb CR, Ford DE, Lehmann H, et al
    Association of sex and atrial fibrillation therapies with patient-reported outcomes.
    Heart. 2019 May 22. pii: heartjnl-2019-314881. doi: 10.1136/heartjnl-2019-314881
    PubMed     Text format     Abstract available


  20. TZEIS S, Asvestas D, Yen Ho S, Vardas P, et al
    Electrocardiographic landmarks of idiopathic ventricular arrhythmia origins.
    Heart. 2019 May 15. pii: heartjnl-2019-314748. doi: 10.1136/heartjnl-2019-314748
    PubMed     Text format     Abstract available


    April 2019
  21. KAPLON-CIESLICKA A, Budnik M, Gawalko M, Peller M, et al
    Atrial fibrillation type and renal dysfunction as important predictors of left atrial thrombus.
    Heart. 2019 Apr 30. pii: heartjnl-2018-314492. doi: 10.1136/heartjnl-2018-314492
    PubMed     Text format     Abstract available


  22. ARBEL R, Sergienko R, Hammerman A, Dotan-Greenberg S, et al
    Direct oral anticoagulation and mortality in moderate to high-risk atrial fibrillation.
    Heart. 2019 Apr 10. pii: heartjnl-2018-314476. doi: 10.1136/heartjnl-2018-314476
    PubMed     Text format     Abstract available


  23. GALLAGHER C, Hendriks JM, Giles L, Karnon J, et al
    Increasing trends in hospitalisations due to atrial fibrillation in Australia from 1993 to 2013.
    Heart. 2019 Apr 1. pii: heartjnl-2018-314471. doi: 10.1136/heartjnl-2018-314471.
    PubMed     Text format     Abstract available


  24. EGBE AC, Miranda WR, Madhavan M, Ammash NM, et al
    Cardiac implantable electronic devices in adults with tetralogy of Fallot.
    Heart. 2019;105:538-544.
    PubMed     Text format     Abstract available


  25. WU KC, Zhang L, Haberlen SA, Ashikaga H, et al
    Predictors of electrocardiographic QT interval prolongation in men with HIV.
    Heart. 2019;105:559-565.
    PubMed     Text format     Abstract available


  26. KILLU AM, Stevenson WG
    Ventricular tachycardia in the absence of structural heart disease.
    Heart. 2019;105:645-656.
    PubMed     Text format    


  27. SANDERS KH, Martin CA, Virdee M
    Sudden-onset severe presyncope in a 67-year-old man.
    Heart. 2019;105:657-659.
    PubMed     Text format     Abstract available


    March 2019
  28. POKORNEY SD, Lopes RD
    Atrial fibrillation: what do we know about screening and what do we not know about treatment?
    Heart. 2019 Mar 21. pii: heartjnl-2018-314518. doi: 10.1136/heartjnl-2018-314518
    PubMed     Text format    


  29. SEJR MH, May O, Damgaard D, Sandal BF, et al
    External continuous ECG versus loop recording for atrial fibrillation detection in patients who had a stroke.
    Heart. 2019 Mar 21. pii: heartjnl-2018-314186. doi: 10.1136/heartjnl-2018-314186
    PubMed     Text format     Abstract available


    February 2019
  30. BURDEN AF, Timpson N
    Ethnicity, heart failure, atrial fibrillation and diabetes: collider bias.
    Heart. 2019 Feb 6. pii: heartjnl-2018-314467. doi: 10.1136/heartjnl-2018-314467.
    PubMed     Text format    


    January 2019
  31. TAN ESJ, Tay WT, Teng TK, Sim D, et al
    Ethnic differences in atrial fibrillation in patients with heart failure from Asia-Pacific.
    Heart. 2019 Jan 19. pii: heartjnl-2018-314077. doi: 10.1136/heartjnl-2018-314077
    PubMed     Text format     Abstract available


  32. BEGG GA, Tayebjee MH
    Unusual fluoroscopic finding during atrial fibrillation cryoablation.
    Heart. 2019 Jan 19. pii: heartjnl-2018-314225. doi: 10.1136/heartjnl-2018-314225
    PubMed     Text format     Abstract available


    December 2018
  33. SBAROUNI E, Kogerakis N, Stavridis G
    68-year-old woman with paroxysmal atrial fibrillation.
    Heart. 2018 Dec 28. pii: heartjnl-2018-314143. doi: 10.1136/heartjnl-2018-314143
    PubMed     Text format     Abstract available


  34. HUANG CY, Lin LY
    Reply: further studies needed before using renin-angiotensin-aldosterone system blockade for atrial fibrillation prevention in hypertrophic cardiomyopathy.
    Heart. 2018;104:1985-1986.
    PubMed     Text format    


  35. RAMCHAND J, Sampaio Rodrigues T, Yudi MB, Burrell LM, et al
    Further studies needed before using renin-angiotensin-aldosterone system blockade for atrial fibrillation prevention in hypertrophic cardiomyopathy.
    Heart. 2018;104:1985.
    PubMed     Text format    


  36. ERWIN III J, Iung B
    Response to: 'Current recommendations for anticoagulant therapy in patients with valvular heart disease and atrial fibrillation: the ACC/AHA and ESC/EACTS Guidelines in Harmony...but not Lockstep!'
    Heart. 2018;104:2077.
    PubMed     Text format    


  37. RIBEIRO AL, Otto CM
    Heartbeat: The worldwide burden of atrial fibrillation.
    Heart. 2018;104:1987-1988.
    PubMed     Text format    


  38. MYERSON SG
    Time to stop using 'non-valvular AF' inappropriately: letter in response to review article.
    Heart. 2018;104:2077.
    PubMed     Text format    


  39. FIDALGO A, Fernandez-Friera L, Solis J
    A 52-year-old woman with ventricular tachycardia.
    Heart. 2018;104:2025-2043.
    PubMed     Text format     Abstract available


  40. DRAKOPOULOU M, Nashat H, Kempny A, Alonso-Gonzalez R, et al
    Arrhythmias in adult patients with congenital heart disease and pulmonary arterial hypertension.
    Heart. 2018;104:1963-1969.
    PubMed     Text format     Abstract available


  41. ALABED S, Providencia R, Chico TJA
    Cochrane corner: adenosine versus intravenous calcium channel antagonists for supraventricular tachycardia.
    Heart. 2018;104:1993-1994.
    PubMed     Text format    


    November 2018
  42. NIEDERDOCKL J, Simon A, Schnaubelt S, Schuetz N, et al
    Cardiac biomarkers predict mortality in emergency patients presenting with atrial fibrillation.
    Heart. 2018 Nov 10. pii: heartjnl-2018-313145. doi: 10.1136/heartjnl-2018-313145
    PubMed     Text format     Abstract available


  43. KUPSKY DF, Ananthasubramaniam K, Lee J
    Eighty-two-year-old man with a systolic murmur.
    Heart. 2018;104:1887-1890.
    PubMed     Text format     Abstract available


  44. GROUTHIER V, Lebrun-Vignes B, Glazer AM, Touraine P, et al
    Increased long QT and torsade de pointes reporting on tamoxifen compared with aromatase inhibitors.
    Heart. 2018;104:1859-1863.
    PubMed     Text format     Abstract available


    October 2018
  45. BERNTSSON J, Smith JG, Johnson LSB, Soderholm M, et al
    Increased vascular endothelial growth factor D is associated with atrial fibrillation and ischaemic stroke.
    Heart. 2018 Oct 16. pii: heartjnl-2018-313684. doi: 10.1136/heartjnl-2018-313684
    PubMed     Text format     Abstract available


  46. HIJAZI Z, Wallentin L
    Natriuretic peptide should be used as a routine tool for evaluation of patients with atrial fibrillation.
    Heart. 2018 Oct 12. pii: heartjnl-2018-314040. doi: 10.1136/heartjnl-2018-314040
    PubMed     Text format    


  47. GLOVER BM, Hong KL, Dagres N, Arbelo E, et al
    Impact of body mass index on the outcome of catheter ablation of atrial fibrillation.
    Heart. 2018 Oct 2. pii: heartjnl-2018-313490. doi: 10.1136/heartjnl-2018-313490.
    PubMed     Text format     Abstract available


    September 2018
  48. NTILOUDI D, Apostolopoulou S, Vasiliadis K, Frogoudaki A, et al
    Hospitalisations for heart failure predict mortality in pulmonary hypertension related to congenital heart disease.
    Heart. 2018 Sep 29. pii: heartjnl-2018-313613. doi: 10.1136/heartjnl-2018-313613
    PubMed     Text format     Abstract available


  49. INOHARA T, Kim S, Pieper K, Blanco RG, et al
    B-type natriuretic peptide, disease progression and clinical outcomes in atrial fibrillation.
    Heart. 2018 Sep 18. pii: heartjnl-2018-313642. doi: 10.1136/heartjnl-2018-313642
    PubMed     Text format     Abstract available


  50. CHRISTERSSON C, Wallentin L, Andersson U, Alexander JH, et al
    Effect of apixaban compared with warfarin on coagulation markers in atrial fibrillation.
    Heart. 2018 Sep 12. pii: heartjnl-2018-313351. doi: 10.1136/heartjnl-2018-313351
    PubMed     Text format     Abstract available


  51. CHOW CL, Abu Baker B, Mohamed U
    Pacing: a new look. Don't be deceived.
    Heart. 2018;104:1491-1528.
    PubMed     Text format     Abstract available


  52. BARRA S, Providencia R, Boveda S, Duehmke R, et al
    Device complications with addition of defibrillation to cardiac resynchronisation therapy for primary prevention.
    Heart. 2018;104:1529-1535.
    PubMed     Text format     Abstract available


    August 2018
  53. PETERS SAE, Woodward M
    Established and novel risk factors for atrial fibrillation in women compared with men.
    Heart. 2018 Aug 29. pii: heartjnl-2018-313630. doi: 10.1136/heartjnl-2018-313630
    PubMed     Text format     Abstract available


  54. HUANG W, Su L, Wu S, Xu L, et al
    Long-term outcomes of His bundle pacing in patients with heart failure with left bundle branch block.
    Heart. 2018 Aug 9. pii: heartjnl-2018-313415. doi: 10.1136/heartjnl-2018-313415.
    PubMed     Text format     Abstract available


  55. OTTO CM
    Heartbeat: Causes and consequences of atrial fibrillation.
    Heart. 2018;104:1229-1231.
    PubMed     Text format    


  56. HUTCHINGS DC, Anderson SG, Caldwell JL, Trafford AW, et al
    Phosphodiesterase-5 inhibitors and the heart: compound cardioprotection?
    Heart. 2018;104:1244-1250.
    PubMed     Text format     Abstract available


  57. TONG C, Kiess M, Deyell MW, Qiu M, et al
    Impact of frequent premature ventricular contractions on pregnancy outcomes.
    Heart. 2018;104:1370-1375.
    PubMed     Text format     Abstract available


    July 2018
  58. SANDHU RK, Ezekowitz JA
    Is incentivising stroke prevention therapy in atrial fibrillation the key?
    Heart. 2018 Jul 10. pii: heartjnl-2018-313402. doi: 10.1136/heartjnl-2018-313402
    PubMed     Text format    


  59. ADDERLEY NJ, Ryan R, Nirantharakumar K, Marshall T, et al
    Prevalence and treatment of atrial fibrillation in UK general practice from 2000 to 2016.
    Heart. 2018 Jul 10. pii: heartjnl-2018-312977. doi: 10.1136/heartjnl-2018-312977
    PubMed     Text format     Abstract available


  60. CALDEIRA D, Ferreira JJ, Pinto FJ, Costa J, et al
    Non-vitamin K antagonist oral anticoagulants and infective endocarditis.
    Heart. 2018;104:1135-1136.
    PubMed     Text format    


  61. OTTO CM
    Heartbeat: cardiovascular disease risk and reproductive factors in women.
    Heart. 2018;104:1045-1047.
    PubMed     Text format    


  62. HARRIS AW, Kudenchuk PJ
    Cardiopulmonary resuscitation: the science behind the hands.
    Heart. 2018;104:1056-1061.
    PubMed     Text format     Abstract available


  63. KUTTY S, Danford DA, Diller GP, Tutarel O, et al
    Contemporary management and outcomes in congenitally corrected transposition of the great arteries.
    Heart. 2018;104:1148-1155.
    PubMed     Text format     Abstract available


    June 2018
  64. HENDRIKS JM, Gallagher C, Middeldorp ME, Sanders P, et al
    New approaches to detection of atrial fibrillation.
    Heart. 2018 Jun 20. pii: heartjnl-2018-313423. doi: 10.1136/heartjnl-2018-313423
    PubMed     Text format    


  65. PATEL NJ, Atti V, Mitrani RD, Viles-Gonzalez JF, et al
    Global rising trends of atrial fibrillation: a major public health concern.
    Heart. 2018 Jun 15. pii: heartjnl-2018-313350. doi: 10.1136/heartjnl-2018-313350
    PubMed     Text format    


  66. DURHEIM MT, Holmes DN, Blanco RG, Allen LA, et al
    Characteristics and outcomes of adults with chronic obstructive pulmonary disease and atrial fibrillation.
    Heart. 2018 Jun 6. pii: heartjnl-2017-312735. doi: 10.1136/heartjnl-2017-312735.
    PubMed     Text format     Abstract available


  67. SEYERLE AA, Lin HJ, Gogarten SM, Stilp A, et al
    Genome-wide association study of PR interval in Hispanics/Latinos identifies novel locus at ID2.
    Heart. 2018;104:904-911.
    PubMed     Text format     Abstract available


  68. FRANCIS R, Lewis C
    Myocardial biopsy: techniques and indications.
    Heart. 2018;104:950-958.
    PubMed     Text format    


  69. OTTO CM
    Heartbeat: socioeconomic deprivation is associated with non-cardiovascular mortality in chronic heart failure patients.
    Heart. 2018;104:961-963.
    PubMed     Text format    


    May 2018
  70. POH MZ, Poh YC, Chan PH, Wong CK, et al
    Diagnostic assessment of a deep learning system for detecting atrial fibrillation in pulse waveforms.
    Heart. 2018 May 31. pii: heartjnl-2018-313147. doi: 10.1136/heartjnl-2018-313147
    PubMed     Text format     Abstract available


  71. BOKMA JP, Geva T, Sleeper LA, Babu Narayan SV, et al
    A propensity score-adjusted analysis of clinical outcomes after pulmonary valve replacement in tetralogy of Fallot.
    Heart. 2018;104:738-744.
    PubMed     Text format     Abstract available


    April 2018
  72. KIM D, Yang PS, Jang E, Yu HT, et al
    Increasing trends in hospital care burden of atrial fibrillation in Korea, 2006 through 2015.
    Heart. 2018 Apr 17. pii: heartjnl-2017-312930. doi: 10.1136/heartjnl-2017-312930
    PubMed     Text format     Abstract available


  73. LARSSON SC, Drca N, Bjorck M, Back M, et al
    Nut consumption and incidence of seven cardiovascular diseases.
    Heart. 2018 Apr 16. pii: heartjnl-2017-312819. doi: 10.1136/heartjnl-2017-312819
    PubMed     Text format     Abstract available


  74. WADIA SK, Lluri G, Aboulhosn JA, Shivkumar K, et al
    Ventricular arrhythmia burden after transcatheter versus surgical pulmonary valve replacement.
    Heart. 2018 Apr 10. pii: heartjnl-2017-312769. doi: 10.1136/heartjnl-2017-312769
    PubMed     Text format     Abstract available


  75. BISSON A, Bodin A, Fauchier L
    Why and how to screen for atrial fibrillation.
    Heart. 2018 Apr 5. pii: heartjnl-2018-313085. doi: 10.1136/heartjnl-2018-313085.
    PubMed     Text format    


  76. LOWN M, Shah BN, Corbett SJ, Yue A, et al
    Response to: 'Screening for atrial fibrillation in hospitalised geriatric patients' by Tavernier et al.
    Heart. 2018;104:624.
    PubMed     Text format    


  77. VIZZI V, Di Biasi M, Alessandrino G, Colombo A, et al
    Left atrial appendage occlusion in high-risk patients: doing it is better than nothing.
    Heart. 2018;104:625.
    PubMed     Text format    


  78. MASOUD A, Bartoletti S, Fairbairn T, Khurana A, et al
    Outcome of left atrial appendage occlusion in high-risk patients.
    Heart. 2018;104:594-599.
    PubMed     Text format     Abstract available


    March 2018
  79. LINKER DT, Murphy TB, Mokdad AH
    Selective screening for atrial fibrillation using multivariable risk models.
    Heart. 2018 Mar 28. pii: heartjnl-2017-312686. doi: 10.1136/heartjnl-2017-312686
    PubMed     Text format     Abstract available


  80. WACHTELL K
    Atrial fibrillation is target organ damage caused by an impaired haemodynamic state.
    Heart. 2018 Mar 24. pii: heartjnl-2017-312778. doi: 10.1136/heartjnl-2017-312778
    PubMed     Text format    


  81. B SCHNABEL R, Pecen L, Engler D, Lucerna M, et al
    Atrial fibrillation patterns are associated with arrhythmia progression and clinical outcomes.
    Heart. 2018 Mar 17. pii: heartjnl-2017-312569. doi: 10.1136/heartjnl-2017-312569
    PubMed     Text format     Abstract available


  82. BETTENCOURT P, Lourenco P
    Atrial fibrillation, a difficulty in the heart failure screening with natriuretic peptides.
    Heart. 2018 Mar 16. pii: heartjnl-2017-312910. doi: 10.1136/heartjnl-2017-312910
    PubMed     Text format    


  83. VAN DOORN S, Geersing GJ, Kievit RF, van Mourik Y, et al
    Opportunistic screening for heart failure with natriuretic peptides in patients with atrial fibrillation: a meta-analysis of individual participant data of four screening studies.
    Heart. 2018 Mar 16. pii: heartjnl-2017-312781. doi: 10.1136/heartjnl-2017-312781
    PubMed     Text format     Abstract available


  84. LAUNEY Y, Seguin P
    Is traumatic intracranial haemorrhage a specific risk factor for atrial fibrillation?
    Heart. 2018;104:450.
    PubMed     Text format    


  85. WAGNER F, Gebauer RA, Paech C
    Newborn in cardiogenic shock.
    Heart. 2018;104:467.
    PubMed     Text format     Abstract available


    February 2018
  86. YUYUN MF, Squire IB, Ng GA, Samani NJ, et al
    Evidence for reduced susceptibility to cardiac bradycardias in South Asians compared with Caucasians.
    Heart. 2018 Feb 20. pii: heartjnl-2017-312374. doi: 10.1136/heartjnl-2017-312374
    PubMed     Text format     Abstract available


  87. IUNG B, Leenhardt A, Extramiana F
    Management of atrial fibrillation in patients with rheumatic mitral stenosis.
    Heart. 2018 Feb 16. pii: heartjnl-2017-311425. doi: 10.1136/heartjnl-2017-311425
    PubMed     Text format     Abstract available


  88. TIKHONOFF V, Kuznetsova T, Thijs L, Cauwenberghs N, et al
    Ambulatory blood pressure and long-term risk for atrial fibrillation.
    Heart. 2018 Feb 9. pii: heartjnl-2017-312488. doi: 10.1136/heartjnl-2017-312488.
    PubMed     Text format     Abstract available


  89. COWIE MR, Zakeri R
    Preventing stroke in patients with heart failure: why are patients losing out?
    Heart. 2018 Feb 2. pii: heartjnl-2017-312862. doi: 10.1136/heartjnl-2017-312862.
    PubMed     Text format    


  90. HAWKINS NM, Grubisic M, Andrade JG, Huang F, et al
    Long-term complications, reoperations and survival following cardioverter-defibrillator implant.
    Heart. 2018;104:237-243.
    PubMed     Text format     Abstract available


  91. MANGLA A, Bjorklund JK, Kalra DK
    An unusual echo after ventricular tachycardia ablation.
    Heart. 2018;104:359-360.
    PubMed     Text format    


    January 2018
  92. HUANG CY, Yang YH, Lin LY, Tsai CT, et al
    Renin-angiotensin-aldosterone blockade reduces atrial fibrillation in hypertrophic cardiomyopathy.
    Heart. 2018 Jan 25. pii: heartjnl-2017-312573. doi: 10.1136/heartjnl-2017-312573
    PubMed     Text format     Abstract available


  93. SAVARESE G, Sartipy U, Friberg L, Dahlstrom U, et al
    Reasons for and consequences of oral anticoagulant underuse in atrial fibrillation with heart failure.
    Heart. 2018 Jan 25. pii: heartjnl-2017-312720. doi: 10.1136/heartjnl-2017-312720
    PubMed     Text format     Abstract available


  94. AKOUM N
    Persistently high incidence of postcoronary bypass atrial fibrillation: possible mechanisms.
    Heart. 2018 Jan 19. pii: heartjnl-2017-312627. doi: 10.1136/heartjnl-2017-312627
    PubMed     Text format    


  95. VINEREANU D, Wang A, Mulder H, Lopes RD, et al
    Outcomes in anticoagulated patients with atrial fibrillation and with mitral or aortic valve disease.
    Heart. 2018 Jan 19. pii: heartjnl-2017-312272. doi: 10.1136/heartjnl-2017-312272
    PubMed     Text format     Abstract available


  96. FILARDO G, Damiano RJ Jr, Ailawadi G, Thourani VH, et al
    Epidemiology of new-onset atrial fibrillation following coronary artery bypass graft surgery.
    Heart. 2018 Jan 11. pii: heartjnl-2017-312150. doi: 10.1136/heartjnl-2017-312150
    PubMed     Text format     Abstract available


  97. ERWIN JP 3RD, Iung B
    Current recommendations for anticoagulant therapy in patients with valvular heart disease and atrial fibrillation: the ACC/AHA and ESC/EACTS Guidelines in Harmony...but not Lockstep!
    Heart. 2018 Jan 11. pii: heartjnl-2017-312758. doi: 10.1136/heartjnl-2017-312758
    PubMed     Text format    


  98. ALONSO A, MacLehose RF, Chen LY, Bengtson LGS, et al
    Oral anticoagulants and liver injury: the threat of uncontrolled confounding.
    Heart. 2018;104:84.
    PubMed     Text format    


    December 2017
  99. SIONTIS GCM, Praz F, Lanz J, Vollenbroich R, et al
    New-onset arrhythmias following transcatheter aortic valve implantation: a systematic review and meta-analysis.
    Heart. 2017 Dec 23. pii: heartjnl-2017-312310. doi: 10.1136/heartjnl-2017-312310
    PubMed     Text format     Abstract available


  100. OTTO CM
    Heartbeat: Healthcare approaches to reducing adverse outcomes in patients with atrial fibrillation.
    Heart. 2017;103:1925-1927.
    PubMed     Text format    


  101. MARTENS P, Verbrugge FH, Nijst P, Dupont M, et al
    Incremental benefit of cardiac resynchronisation therapy with versus without a defibrillator.
    Heart. 2017;103:1977-1984.
    PubMed     Text format     Abstract available


    November 2017
  102. BORIANI G, Proietti M
    Atrial fibrillation prevention: an appraisal of current evidence.
    Heart. 2017 Nov 30. pii: heartjnl-2017-311546. doi: 10.1136/heartjnl-2017-311546
    PubMed     Text format     Abstract available


  103. PATTI G
    Patients with atrial fibrillation and coronary events: are we any closer to coming out from the labyrinth of the various antithrombotic strategies?
    Heart. 2017 Nov 25. pii: heartjnl-2017-312576. doi: 10.1136/heartjnl-2017-312576
    PubMed     Text format    


  104. SINDET-PEDERSEN C, Staerk L, Lamberts M, Gerds TA, et al
    Use of oral anticoagulants in combination with antiplatelet(s) in atrial fibrillation.
    Heart. 2017 Nov 1. pii: heartjnl-2017-311976. doi: 10.1136/heartjnl-2017-311976.
    PubMed     Text format     Abstract available


  105. LAZZERINI PE, Laghi-Pasini F, Bertolozzi I, Morozzi G, et al
    Systemic inflammation as a novel QT-prolonging risk factor in patients with torsades de pointes.
    Heart. 2017;103:1821-1829.
    PubMed     Text format     Abstract available


    October 2017
  106. CORTIGIANI L, Carpeggiani C, Sicari R, Michelassi C, et al
    Simple six-item clinical score improves risk prediction capability of stress echocardiography.
    Heart. 2017 Oct 14. pii: heartjnl-2017-312122. doi: 10.1136/heartjnl-2017-312122
    PubMed     Text format     Abstract available


  107. WONG JA, Rexrode KM, Sandhu RK, Moorthy MV, et al
    Menopausal age, postmenopausal hormone therapy and incident atrial fibrillation.
    Heart. 2017 Oct 7. pii: heartjnl-2016-311002. doi: 10.1136/heartjnl-2016-311002.
    PubMed     Text format     Abstract available


  108. MARTIN CA, Gajendragadkar PR, Agarwal S
    Palpitations in a 72-year-old woman.
    Heart. 2017;103:1554-1555.
    PubMed     Text format     Abstract available


  109. MARTIN CA, Lambiase PD
    Pathophysiology, diagnosis and treatment of tachycardiomyopathy.
    Heart. 2017;103:1543-1552.
    PubMed     Text format    


    September 2017
  110. PROVIDENCIA R, Karim N, Srinivasan N, Honarbakhsh S, et al
    Impact of QTc formulae in the prevalence of short corrected QT interval and impact on probability and diagnosis of short QT syndrome.
    Heart. 2017 Sep 27. pii: heartjnl-2017-311673. doi: 10.1136/heartjnl-2017-311673
    PubMed     Text format     Abstract available


  111. LIU K, Ahmed J, Feiglin D
    A 54-year-old man with new-onset ventricular fibrillation.
    Heart. 2017 Sep 27. pii: heartjnl-2017-312052. doi: 10.1136/heartjnl-2017-312052
    PubMed     Text format     Abstract available


  112. BAPAT A, Anderson CD, Ellinor PT, Lubitz SA, et al
    Genomic basis of atrial fibrillation.
    Heart. 2017 Sep 11. pii: heartjnl-2016-311027. doi: 10.1136/heartjnl-2016-311027
    PubMed     Text format     Abstract available


  113. TAVERNIER R, Wolf M, Kataria V, Phlips T, et al
    Screening for atrial fibrillation in hospitalised geriatric patients.
    Heart. 2017 Sep 7. pii: heartjnl-2017-311981. doi: 10.1136/heartjnl-2017-311981.
    PubMed     Text format     Abstract available


  114. RAOUF WA, Shams K, Mansour A
    An unusual cause of tachyarrhythmia in an otherwise healthy young man.
    Heart. 2017;103:1472.
    PubMed     Text format     Abstract available


  115. HONARBAKHSH S, Baker V, Kirkby C, Patel K, et al
    Safety and efficacy of paramedic treatment of regular supraventricular tachycardia: a randomised controlled trial.
    Heart. 2017;103:1413-1418.
    PubMed     Text format     Abstract available


  116. ZUMHAGEN S, Vrachimis A, Stegger L, Kies P, et al
    Impact of presynaptic sympathetic imbalance in long-QT syndrome by positron emission tomography.
    Heart. 2017 Sep 1. pii: heartjnl-2017-311667. doi: 10.1136/heartjnl-2017-311667.
    PubMed     Text format     Abstract available


  117. BROUGH C
    Expediting the pathway to supraventricular tachycardia ablation.
    Heart. 2017;103:1471.
    PubMed     Text format    


  118. MCLEOD CJ
    Acute arrhythmias in adults with congenital heart disease.
    Heart. 2017;103:1380-1388.
    PubMed     Text format    


    August 2017
  119. BHAVE PD
    What do our patients think they know about atrial fibrillation? ... Is that asking the right question?
    Heart. 2017 Aug 16. pii: heartjnl-2017-312124. doi: 10.1136/heartjnl-2017-312124
    PubMed     Text format    


  120. KAUFMAN BG, Kim S, Pieper K, Allen LA, et al
    Disease understanding in patients newly diagnosed with atrial fibrillation.
    Heart. 2017 Aug 8. pii: heartjnl-2017-311800. doi: 10.1136/heartjnl-2017-311800.
    PubMed     Text format     Abstract available


  121. GUHL EN, Magnani JW
    Atrial fibrillation and menopause: something else to worry about, or not?
    Heart. 2017 Aug 5. pii: heartjnl-2017-311771. doi: 10.1136/heartjnl-2017-311771.
    PubMed     Text format    


  122. OTTO CM
    Heartbeat: Chocolate and atrial fibrillation.
    Heart. 2017;103:1139-1140.
    PubMed     Text format    


  123. GOUDA P, Veenhuyzen G, Har B
    Fifty-year-old woman with lightheadedness.
    Heart. 2017;103:1224.
    PubMed     Text format    


    July 2017
  124. CHUE CD, Kwok CS, Wong CW, Patwala A, et al
    Efficacy and safety of the subcutaneous implantable cardioverter defibrillator: a systematic review.
    Heart. 2017 Jul 7. pii: heartjnl-2016-310852. doi: 10.1136/heartjnl-2016-310852.
    PubMed     Text format     Abstract available


  125. STEWART S
    Bringing order to chaos: the case for integrated management of atrial fibrillation.
    Heart. 2017 Jul 6. pii: heartjnl-2017-311519. doi: 10.1136/heartjnl-2017-311519.
    PubMed     Text format    


  126. RYDMAN R, Shiina Y, Diller GP, Niwa K, et al
    Major adverse events and atrial tachycardia in Ebstein's anomaly predicted by cardiovascular magnetic resonance.
    Heart. 2017 Jul 6. pii: heartjnl-2017-311274. doi: 10.1136/heartjnl-2017-311274.
    PubMed     Text format     Abstract available


    June 2017
  127. GHANNAM M, Chugh A
    Indications and appropriate selection of novel oral anticoagulants in patients with atrial fibrillation.
    Heart. 2017 Jun 17. pii: heartjnl-2014-307030. doi: 10.1136/heartjnl-2014-307030
    PubMed     Text format    


  128. ISAEW A, Adderley NJ, Ryan R, Fitzmaurice D, et al
    The treatment of paroxysmal atrial fibrillation in UK primary care.
    Heart. 2017 Jun 1. pii: heartjnl-2016-310927. doi: 10.1136/heartjnl-2016-310927.
    PubMed     Text format     Abstract available


  129. BROENDBERG AK, Nielsen JC, Bjerre J, Pedersen LN, et al
    Nationwide experience of catecholaminergic polymorphic ventricular tachycardia caused by RyR2 mutations.
    Heart. 2017;103:901-909.
    PubMed     Text format     Abstract available


  130. LIEW AC, Raphael CE, Mohiaddin R
    A 38-year-old man with progressive dyspnoea and ventricular tachycardia.
    Heart. 2017;103:839.
    PubMed     Text format     Abstract available


  131. PFLAUMER A
    Catecholaminergic polymorphic tachycardia: underestimated and overtreated?
    Heart. 2017;103:889-890.
    PubMed     Text format    


  132. POTPARA TS, Lip GY
    Drug-induced liver injury with oral anticoagulants: a threat or not?
    Heart. 2017;103:809-811.
    PubMed     Text format    


  133. WATSON W, Ring L, Salahshouri P
    84-year-old woman with dizziness.
    Heart. 2017;103:966.
    PubMed     Text format    


  134. HENEGHAN CJ, Spencer EA, Mahtani KR
    Cochrane corner: self-monitoring and self-management of oral anticoagulation.
    Heart. 2017;103:895-896.
    PubMed     Text format    


    May 2017
  135. MOSTOFSKY E, Berg Johansen M, Tjonneland A, Chahal HS, et al
    Chocolate intake and risk of clinically apparent atrial fibrillation: the Danish Diet, Cancer, and Health Study.
    Heart. 2017 May 23. pii: heartjnl-2016-310357. doi: 10.1136/heartjnl-2016-310357
    PubMed     Text format     Abstract available


  136. POKORNEY SD, Piccini JP
    Chocolate and prevention of atrial fibrillation: what is bad for the pancreas might be good for the atria?
    Heart. 2017 May 23. pii: heartjnl-2016-311026. doi: 10.1136/heartjnl-2016-311026
    PubMed     Text format    


  137. GALLAGHER C, Elliott AD, Wong CX, Rangnekar G, et al
    Integrated care in atrial fibrillation: a systematic review and meta-analysis.
    Heart. 2017 May 10. pii: heartjnl-2016-310952. doi: 10.1136/heartjnl-2016-310952
    PubMed     Text format     Abstract available


  138. BOKMA JP, Winter MM, Vehmeijer JT, Vliegen HW, et al
    QRS fragmentation is superior to QRS duration in predicting mortality in adults with tetralogy of Fallot.
    Heart. 2017;103:666-671.
    PubMed     Text format     Abstract available


  139. VON ROTZ M, Aeschbacher S, Bossard M, Schoen T, et al
    Risk factors for premature ventricular contractions in young and healthy adults.
    Heart. 2017;103:702-707.
    PubMed     Text format     Abstract available


  140. HENG EL, Gatzoulis MA
    QRS fragmentation in tetralogy of Fallot: clinical utility and risk prediction.
    Heart. 2017;103:645-646.
    PubMed     Text format    


    April 2017
  141. POTPARA TS, Blomstrom-Lundqvist C
    Sex-related differences in atrial fibrillation: can we discern true disparities from biases?
    Heart. 2017 Apr 29. pii: heartjnl-2016-311085. doi: 10.1136/heartjnl-2016-311085
    PubMed     Text format    


  142. MINAMI Y, Hagiwara N
    Enlarged left atrium, atrial fibrillation and adverse outcome in hypertrophic cardiomyopathy: is there a difference between apical and non-apical phenotype?
    Heart. 2017 Apr 28. pii: heartjnl-2017-311501. doi: 10.1136/heartjnl-2017-311501
    PubMed     Text format    


  143. LEE SE, Park JK, Uhm JS, Kim JY, et al
    Impact of atrial fibrillation on the clinical course of apical hypertrophic cardiomyopathy.
    Heart. 2017 Apr 20. pii: heartjnl-2016-310720. doi: 10.1136/heartjnl-2016-310720
    PubMed     Text format     Abstract available


  144. LIN WS, Lin TC, Hung Y, Lin WY, et al
    Traumatic intracranial haemorrhage is in association with an increased risk of subsequent atrial fibrillation.
    Heart. 2017 Apr 7. pii: heartjnl-2016-310451. doi: 10.1136/heartjnl-2016-310451.
    PubMed     Text format     Abstract available


  145. HENDRIKS JM, Gallagher C, Sanders P
    Ensuring adherence to therapy with anticoagulation in patients with atrial fibrillation.
    Heart. 2017 Apr 7. pii: heartjnl-2017-311305. doi: 10.1136/heartjnl-2017-311305.
    PubMed     Text format    


  146. YEO C, Tan VH, Wong KC
    Exercise-induced syncope in a 22-year-old man.
    Heart. 2017;103:642.
    PubMed     Text format     Abstract available


  147. AMBALE-VENKATESH B, Yoneyama K, Sharma RK, Ohyama Y, et al
    Left ventricular shape predicts different types of cardiovascular events in the general population.
    Heart. 2017;103:499-507.
    PubMed     Text format     Abstract available


    March 2017
  148. BENOIST D, Dubes V, Roubertie F, Gilbert SH, et al
    Proarrhythmic remodelling of the right ventricle in a porcine model of repaired tetralogy of Fallot.
    Heart. 2017;103:347-354.
    PubMed     Text format     Abstract available


  149. HAGNAS MJ, Lakka TA, Kurl S, Rauramaa R, et al
    Cardiorespiratory fitness and exercise-induced ST segment depression in assessing the risk of sudden cardiac death in men.
    Heart. 2017;103:383-389.
    PubMed     Text format     Abstract available


    January 2017
  150. OTTO CM
    Heartbeat: Left atrial appendage occlusion for stroke prevention.
    Heart. 2017;103:89-90.
    PubMed     Text format    


    August 2016
  151. CUYPERS JA, Menting ME, Opic P, Utens EM, et al
    The unnatural history of pulmonary stenosis up to 40 years after surgical repair.
    Heart. 2016 Aug 11. pii: heartjnl-2015-309159. doi: 10.1136/heartjnl-2015-309159
    PubMed     Text format     Abstract available


    June 2016
  152. DHILLON A, Khanna A, Randhawa MS, Cywinski J, et al
    Perioperative outcomes of patients with hypertrophic cardiomyopathy undergoing non-cardiac surgery.
    Heart. 2016 Jun 10. pii: heartjnl-2016-309442. doi: 10.1136/heartjnl-2016-309442
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Arrhythmias is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: